Converge Bio empowers CROs to deliver next-gen antibody, manufacturing, and cell simulation services without building in-house AI infrastructure, offering white-labeled or internal-use campaigns that enhance client value. With Converge, you get the tools, the models, and the expert team to focus on results.

Generate and refine antibody sequences across formats (IgG, scFv, VHH, nanobodies)
Rank and optimize candidates using AI predictions for affinity, developability, and docking
Campaign types: candidate selection, lead optimization, epitope-specific de novo design, humanization
Enable your clients to reach high-quality antibody candidates faster with AI-optimized discovery and engineering
IgG
VHH
ScFv
Bispecific
Optimize transcripts for expression yield in CHO, HEK, Pichia, or E. coli
Incorporate codon usage, UTR and promoter optimization and RNA structure modeling
Predict and rank transcript variants by expected yield
Offer expression optimization as a value-added service for biologics development, clone selection, or platform-strain improvement

Fully hosted and operated on Converge’s servers, including cloud costs and maintenance
On-demand fine-tuning on CRO’s or client’s proprietary data
Regular updates and improvements to the ConvergeAB foundational platform
Priority technical and scientific support
Customized exclusive instance
Campaigns
A key benefit is speed—we deliver fast turnaround times for computational tasks, such as candidate selection within days and yield optimization in a single day. This gives you and your clients a flexible model and quick time to value.
Generated molecules are fully owned by you, and your data stays entirely private - never used to train our models.